Page 82 - Amgen News Today

Undergraduate Research Week is set for April 15-19, and the U of A is celebrating with a slate of information sessions, panel discussions and advising opportunities, in addition to its annual poster competition.

Ascension Capital Advisors Inc. trimmed its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 52.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 800 shares of the medical research company’s stock after selling 872 shares during the period. Amgen accounts […]

The new era in biotech is defined by the convergence of biology, data, and artificial intelligence.

Toth Financial Advisory Corp raised its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 2.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 28,086 shares of the medical research company’s stock after acquiring an additional 592 […]

Rainsberger Wealth Advisors Inc. bought a new position in Amgen Inc. (NASDAQ:AMGN – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 2,390 shares of the medical research company’s stock, valued at approximately $688,000. A number of other hedge funds and other […]

Ascension Capital Advisors Inc. lowered its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 52.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 800 shares of the medical research company’s stock after selling 872 shares during the […]

Toth Financial Advisory Corp raised its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 2.2% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 28,086 shares of the medical research company’s stock after purchasing an additional 592 shares during the quarter. […]

Hemington Wealth Management boosted its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 19.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,050 shares of the medical research company’s stock after acquiring an additional 496 shares […]

Aull & Monroe Investment Management Corp lessened its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 1.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 12,440 shares of the medical research company’s stock after selling 224 shares during the quarter. Amgen […]

Hemington Wealth Management boosted its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 19.4% during the 4th quarter, HoldingsChannel reports. The firm owned 3,050 shares of the medical research company’s stock after buying an additional 496 shares during the quarter. Hemington Wealth Management’s holdings in Amgen were worth $878,000 as of its most recent […]